Cargando…
The Brain as a Drug Target /
The brain is protected by the blood-brain barrier and this barrier prevents many drugs from entering the brain. This volume discusses various drug delivery and targeting strategies that are being developed to enhance the transport and distribution of drugs into the brain. * Discusses new discoveries...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Elsevier/Academic Press,
2011.
|
| Colección: | Progress in molecular biology and translational science ;
v. 98. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ii 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn702364477 | ||
| 003 | OCoLC | ||
| 005 | 20231117044550.0 | ||
| 006 | m o d | ||
| 007 | cr mnu---unuuu | ||
| 008 | 110217s2011 ne af ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d YDXCP |d E7B |d OSU |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d OCLCO |d IDEBK |d S4S |d OCLCQ |d OCLCO |d FDA |d OCLCO |d OCLCQ |d UAB |d OTZ |d OCLCQ |d MEU |d D6H |d OCLCQ |d LEAUB |d OL$ |d UKBTH |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 742298452 |a 816635267 |a 823126909 |a 823849662 |a 823919597 |a 824102607 |a 824163352 |a 1159657541 |a 1162006015 | ||
| 020 | |a 9780123855077 |q (electronic bk.) | ||
| 020 | |a 0123855071 |q (electronic bk.) | ||
| 020 | |a 9780123855060 |q (electronic bk.) | ||
| 020 | |a 0123855063 |q (electronic bk.) | ||
| 020 | |a 1282968890 | ||
| 020 | |a 9781282968899 | ||
| 020 | |a 9786612968891 | ||
| 020 | |a 6612968893 | ||
| 035 | |a (OCoLC)702364477 |z (OCoLC)742298452 |z (OCoLC)816635267 |z (OCoLC)823126909 |z (OCoLC)823849662 |z (OCoLC)823919597 |z (OCoLC)824102607 |z (OCoLC)824163352 |z (OCoLC)1159657541 |z (OCoLC)1162006015 | ||
| 050 | 4 | |a RM315 |b .B73 2011eb | |
| 072 | 7 | |a MED |x 093000 |2 bisacsh | |
| 072 | 7 | |a MED |x 105020 |2 bisacsh | |
| 072 | 7 | |a MJN, MMG |2 bicssc | |
| 082 | 0 | 4 | |a 615/.78 |2 22 |
| 245 | 0 | 4 | |a The Brain as a Drug Target / |c edited by Shafiqur Rahman. |
| 264 | 1 | |a Amsterdam ; |a Boston : |b Elsevier/Academic Press, |c 2011. | |
| 300 | |a 1 online resource (xiv, 453 pages, 2 unnumbered pages of plates) : |b illustrations (some color). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Progress in molecular biology and translational science ; |v v. 98 | |
| 546 | |a Text in English. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 520 | |a The brain is protected by the blood-brain barrier and this barrier prevents many drugs from entering the brain. This volume discusses various drug delivery and targeting strategies that are being developed to enhance the transport and distribution of drugs into the brain. * Discusses new discoveries, approaches, and ideas * Contributions from leading scholars and industry experts * Reference guide for researchers involved in molecular biology and related fields. | ||
| 505 | 0 | |a Front Cover; Progress in Molecular Biology and Translational Science: The Brain as a Drug Target; Copyright; Contents; Contributors; Preface; Chapter 1: Monoamine Transporters: Vulnerable and Vital Doorkeepers; I. Introduction; II. Clinical Benefits: Demonstration of the Medical Roles of Monoamine Transporters; III. Preclinical Indications-Behavioral Pharmacology; IV. Molecular Study: cDNA Cloning and Structure Activity Relationship; V. Protein Regulations; VI. Animal Genetics; VII. The Transporter Genes as Risk Factors; VIII. Perspectives for Medication Development; Acknowledgments | |
| 505 | 8 | |a VI. Future Directions for Optimization of Treatment RegimensReferences; Chapter 4: Insulin, Synaptic Function, and Opportunities for Neuroprotection; I. Introduction; II. Insulin Within the Central Nervous System; III. Insulin Receptors Within the Brain; IV. Insulin Signaling and Synaptic Function; V. Therapeutic Opportunities: Insulin and Neuroprotection; VI. General Summary; References; Chapter 5: Molecular Alterations in Glioblastoma: PotentialTargets for Immunotherapy; I. Introduction; II. Genetic Alterations in Glioblastoma; III. Ags and Biomarkers in Glioblastoma | |
| 505 | 8 | |a IV. Ag-Specific Immunotherapy for GlioblastomaV. Biomarker-Specific Chemotherapy for Glioblastoma; VI. Cytokine-Based Immunotherapy for Glioblastoma; VII. Chemoimmunotherapy for Glioblastoma; VIII. Tumor-Associated Molecules Influencing Glioblastoma Immunotherapy; IX. Conclusions; Acknowledgments; References; Chapter 6: Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System; I. Introduction to the Corticotropin Releasing Factor Peptide Family; II. Neural CRF Distribution; III. CRF Binding and Signal Transduction | |
| 505 | 8 | |a IV. Genes and Gene Systems Activated by CRFV. Interactions with Other Neural Circuits; VI. Translational Significance of CRF; VII. Integrated CRF Function; References; Chapter 7: Molecular Targets of Alcohol Action: Translational Research for Pharmacotherapy Development and Screening; I. Introduction; II. Alcohol Abuse and Dependence, Significance, and Treatment Needs; III. Preclinical Strategies for Identification of Novel Targets of Alcohol Action; IV. Translational Strategies and Need for Continued Biomarkers Development; References | |
| 650 | 0 | |a Psychotropic drugs. | |
| 650 | 0 | |a Brain |x Effect of drugs on. | |
| 650 | 0 | |a Brain |x Diseases |x Treatment. | |
| 650 | 0 | |a Brain |x Wounds and injuries |x Treatment. | |
| 650 | 2 | |a Psychotropic Drugs |0 (DNLM)D011619 | |
| 650 | 6 | |a Psychotropes. |0 (CaQQLa)201-0001454 | |
| 650 | 6 | |a Cerveau |0 (CaQQLa)201-0003439 |x Effets des m�edicaments sur. |0 (CaQQLa)000273919 | |
| 650 | 6 | |a Cerveau |0 (CaQQLa)201-0001145 |x Maladies |0 (CaQQLa)201-0001145 |x Traitement. |0 (CaQQLa)201-0377521 | |
| 650 | 6 | |a Cerveau |0 (CaQQLa)201-0011413 |x L�esions et blessures |0 (CaQQLa)201-0011413 |x Traitement. |0 (CaQQLa)201-0377521 | |
| 650 | 7 | |a MEDICAL |x Pain Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Psychiatry |x Psychopharmacology. |2 bisacsh | |
| 650 | 7 | |a Brain |x Diseases |x Treatment |2 fast |0 (OCoLC)fst00837618 | |
| 650 | 7 | |a Brain |x Effect of drugs on |2 fast |0 (OCoLC)fst00837623 | |
| 650 | 7 | |a Brain |x Wounds and injuries |x Treatment |2 fast |0 (OCoLC)fst00837709 | |
| 650 | 7 | |a Psychotropic drugs |2 fast |0 (OCoLC)fst01081826 | |
| 700 | 1 | |a Rahman, Shafiqur, |d 1963- |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Brain as a drug target. |d Amsterdam ; Boston : Academic Press/Elsevier, �2011 |z 9780123855060 |w (OCoLC)681501654 |
| 830 | 0 | |a Progress in molecular biology and translational science ; |v v. 98. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123855060 |z Texto completo |